Home/Pipeline/AM-DV-01

AM-DV-01

Dengue fever (ADE prevention)

PreclinicalActive

Key Facts

Indication
Dengue fever (ADE prevention)
Phase
Preclinical
Status
Active
Company

About AcadeMab Biomedical

Taiwan biotech integrating antibody and mRNA‑LNP technologies to target oncology and infectious disease unmet needs.

View full company profile